Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500111017Phase 4Not yet recruiting
Phase 4 trial of remimazolam (3 arms), sponsored by Tongling People's Hospital. Primary endpoint: Offline time. Planned start Oct 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500111017.